XENETIC BIOSCIENCES, INC. License and Services Revenue (Deprecated 2018-01-31)
XENETIC BIOSCIENCES, INC. (XBIO) reported License and Services Revenue (Deprecated 2018-01-31) of $0 for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-14.
Discontinued › Income Statement › Other Income
us-gaap:LicenseAndServicesRevenue · last filed 2017-11-14
- XENETIC BIOSCIENCES, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $0.00.
- XENETIC BIOSCIENCES, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $0.00.
- XENETIC BIOSCIENCES, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $0.00.
- XENETIC BIOSCIENCES, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2016-09-30 was $0.00.
| Period end | License and Services Revenue (Deprecated 2018-01-31) 3 month | License and Services Revenue (Deprecated 2018-01-31) 6 month | License and Services Revenue (Deprecated 2018-01-31) 9 month |
|---|---|---|---|
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-11-14 | $0.00 10-Q · filed 2017-11-14 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-11-14 | $0.00 10-Q · filed 2017-11-14 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-15 | ||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $0.00 10-Q · filed 2016-08-15 | |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |